Searching for novel targets in IO with the co-founder and CEO of Cartography Biosciences

blonca9
Feb 23, 2024
1 min read

Kevin Parker describes how Cartography has been building an antigen map over previous years in search of novel targets in a field otherwise prone to overcrowding.

Recent Posts

See All

As federal funding for cancer research has been jeopardized at NIH and academia, Parker Institute for Cancer Immunotherapy is one private institution ready to step up and broaden its impact

Mount Sinai has embraced AI as a drug discovery tool by launching this month its new AI Small Molecule Drug Discovery Center - Professor Avner Schlessinger tells us why

Jones Healthcare & Technology Innovation Conference: Jones Research analysts Soumit Roy and Justin Walsh share their take on biotech and comment on companies they cover

Searching for novel targets in IO with the co-founder and CEO of Cartography Biosciences

Recent Posts

Join the BiotechTV mailing list

Follow BiotechTV

Sponsors

Sponsor Spotlight